RenovoRx, Inc. (RNXT)
1.67
+0.19
(+12.84%)
USD |
NASDAQ |
Aug 28, 16:00
1.70
+0.03
(+1.80%)
After-Hours: 20:00
RenovoRx Total Assets (Quarterly) : 11.47M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.47M |
| March 31, 2026 | 13.96M |
| December 31, 2025 | 8.144M |
| September 30, 2025 | 11.21M |
| June 30, 2025 | 13.64M |
| March 31, 2025 | 16.01M |
| December 31, 2024 | 8.197M |
| September 30, 2024 | 10.03M |
| June 30, 2024 | 12.00M |
| March 31, 2024 | 4.788M |
| December 31, 2023 | 1.466M |
| Date | Value |
|---|---|
| September 30, 2023 | 3.519M |
| June 30, 2023 | 6.314M |
| March 31, 2023 | 4.561M |
| December 31, 2022 | 7.265M |
| September 30, 2022 | 9.25M |
| June 30, 2022 | 11.24M |
| March 31, 2022 | 13.95M |
| December 31, 2021 | 16.29M |
| September 30, 2021 | 18.18M |
| June 30, 2021 | 2.164M |
| March 31, 2021 | 1.278M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | 296.87M |
| Travere Therapeutics, Inc. | 799.36M |
| REGENXBIO, Inc. | 386.62M |
| Krystal Biotech, Inc. | 1.501B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.493M |
| Shareholders Equity (Quarterly) | 8.979M |
| Debt to Equity Ratio | 0.0434 |
| Current Ratio | 5.738 |
| Net Debt Paydown Yield | -0.05% |